ContraFect

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ContraFect and other ETFs, options, and stocks.

About CFRX

ContraFect Corp. is a clinical stage biotechnology company, which engages in the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its product pipeline consists of CF-301, Gram-Negative Lysins, and Amurin Peptides.

CEO

Roger J. Pomerantz

CEORoger J. Pomerantz

Employees

Employees38

Headquarters

Yonkers, New York

HeadquartersYonkers, New York

Founded

2008

Founded2008

Employees

Employees38

CFRX Key Statistics

Market cap

3.07M

Market cap3.07M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

34.96M

Average volume34.96M

High today

$0.075

High today$0.075

Low today

$0.0634

Low today$0.0634

Open price

$0.0734

Open price$0.0734

Volume

42.41M

Volume42.41M

52 Week high

$4.54

52 Week high$4.54

52 Week low

$0.0634

52 Week low$0.0634

CFRX Earnings

-$0.51

-$0.34

-$0.17

$0.00

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 23, Pre-Market

ActualExpected Mar 23, Pre-Market